Literature DB >> 18499737

Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis.

Léon Mutesa1, Geneviève Pierquin, Karin Segers, Jean François Vanbellinghen, Laetitia Gahimbare, Vincent Bours.   

Abstract

Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease that results from the expansion of an unstable trinucleotide CAG repeat encoding for a polyglutamine tract. In normal individuals, alleles contain between 14 and 31 CAG repeats, whereas the pathological alleles have more than 35 CAG repeats. The clinical phenotype of SCA2 includes a progressive cerebellar ataxia with additional features such as ophthalmoplegia, extra-pyramidal or pyramidal signs and peripheral neuropathy. We report a SCA2 large African family with several affected individuals. A major pathological allele carrying 43 CAG repeats was identified in the proband. To our knowledge, this is a first report of a SCA disorder described in Central African patients, thus indicating the need to consider this diagnosis in young African ataxic patients.

Entities:  

Mesh:

Year:  2008        PMID: 18499737     DOI: 10.1093/tropej/fmn034

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  5 in total

Review 1.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

2.  Clinical and genetic analysis of spinocerebellar ataxia in Mali.

Authors:  M Traoré; T Coulibaly; K G Meilleur; A La Pean; M Sangaré; G Landouré; F Mochel; M Karambé; C O Guinto; K H Fischbeck
Journal:  Eur J Neurol       Date:  2011-03-21       Impact factor: 6.089

3.  A Novel Co-existence of Spinocerebellar Ataxia 1 and Spinocerebellar Ataxia 2 Mutations in Indian Patients.

Authors:  Pooja Sharma; Akhilesh K Sonakar; Vinay Goel; Ajay Garg; Achal K Srivastava; Mohammed Faruq
Journal:  Mov Disord Clin Pract       Date:  2022-05-10

Review 4.  Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Tolulope Oyeniyi; Bruce Ovbiagele; Donna K Arnett; Hemant K Tiwari; Richard Walker; Adesola Ogunniyi; Raj N Kalaria
Journal:  J Neurol Sci       Date:  2016-05-06       Impact factor: 3.181

5.  Medical genetics and genomic medicine in Rwanda.

Authors:  Annette Uwineza; Leon Mutesa
Journal:  Mol Genet Genomic Med       Date:  2015-11-08       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.